Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer - Concepedia

Concepedia

Publication | Closed Access

Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer

25

Citations

27

References

2021

Year

Shigeo Tokumaru, Tomonobu Koizumi, Yasushi Sekino, Nobumichi Takeuchi, Shinji Nakata, Yusuke Miyagawa, Masato Kitazawa, Futoshi Muranaka, Satoshi Nakamura, Makoto Koyama,

Abstract

Thus, the 2wLMR could be a useful biomarker to predict response to nivolumab treatment and the prognosis of unresectable and recurrent gastric cancer.

References

	Year	Citations

Page 1